VentriPoint Diagnostics Ltd VPTDF

Primary Symbol: V.VPT

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon May 16, 2024 6:57am

56 Views

Post# 36042782

🌟 What a fantastic night at the Angiopro Partner Dinner 🎉

What a fantastic night at the Angiopro Partner Dinner during #EuroPCR2024!

Last evening, we had the joy of connecting with our esteemed partners. The night was buzzing with vibrant discussions, valuable insights, and the strengthening of our collaborative bonds.

A heartfelt thank you to all our partners who attended and enriched the evening with your contributions. Your engagement is what drives us forward, fueling innovation in the cardiologic field. Excited for what we can achieve together in the future!

#EuroPCR2024 #Angiopro #CardiologyNetworking #HealthcareInnovation